Addus Homecare Corp current report, 12 September 2026

Addus HomeCare Corp (ADUS) - Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed on September 14, 2026, regarding events occurring on September 12, 2026. Addus HomeCare Corporation (the "Company") announced the entry into a definitive agreement to acquire a significant portion of AccentCare, Inc.'s personal care and community care business.

Key Financial Metrics and Transaction Details

  • Transaction Type: Equity and Asset Purchase Agreement.
  • Purchase Price: $275,000,000 in cash, subject to customary working capital adjustments.
  • Target Assets: The acquisition includes equity interests in ten entities (collectively the "Transferred Entities") across Georgia, Tennessee, Texas, Arizona, Illinois, California, Washington, Minnesota, and Pennsylvania, plus certain assets of a Colorado entity.
  • Exclusions: The transaction excludes AccentCare's business operations within the state of New York.
  • Financing: The transaction is not subject to any financing condition.
  • Financial Performance: The filing text does not provide specific revenue, profit, cash flow, margin, debt, or liquidity metrics for the Company or the target business.

Material Changes and Conditions

The closing of the transaction is contingent upon several conditions, including:

  • Accuracy of representations and warranties.
  • Compliance with covenants.
  • Obtaining necessary regulatory approvals.
  • Expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.

Both parties retain termination rights. The Company has secured representations and warranties insurance. There are no termination or reverse termination fees associated with this agreement.

Outlook, Risks, and Management Commentary

Management has characterized the agreement as a material definitive agreement. The filing does not provide specific forward-looking guidance, detailed risk factors beyond standard closing conditions, or commentary on unusual items. The transaction is expected to expand the Company's footprint in personal and community care outside of New York.

Key Facts for Investor Verification

  • Verify the Company's current cash position and liquidity to confirm the ability to fund the $275 million cash purchase without external financing.
  • Monitor the status of regulatory approvals and the Hart-Scott-Rodino waiting period expiration.
  • Review the attached Purchase Agreement (Exhibit 10.1) for specific working capital adjustment mechanisms and indemnification terms.
  • Confirm the financial performance and customer concentration of the ten Transferred Entities and the Colorado asset seller.
  • Assess the strategic fit and integration costs of the acquired entities outside of New York.